These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33426092)
1. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss? Yang X; Meng T J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092 [TBL] [Abstract][Full Text] [Related]
2. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710 [TBL] [Abstract][Full Text] [Related]
3. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities. Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss. Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929 [TBL] [Abstract][Full Text] [Related]
6. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)]. Sapir T; Carp H; Shoenfeld Y Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561 [TBL] [Abstract][Full Text] [Related]
7. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Mahmoud F; Diejomaoh M; Omu A; Abul H; Haines D Gynecol Obstet Invest; 2004; 58(2):77-83. PubMed ID: 15114031 [TBL] [Abstract][Full Text] [Related]
8. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update. Christiansen OB; Kolte AM; Krog MC; Nielsen HS; Egerup P J Reprod Immunol; 2019 Jun; 133():37-42. PubMed ID: 31238263 [TBL] [Abstract][Full Text] [Related]
9. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss. Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625 [TBL] [Abstract][Full Text] [Related]
10. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin. Stricker RB; Winger EE Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665 [TBL] [Abstract][Full Text] [Related]
11. Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Lee SK; Na BJ; Kim JY; Hur SE; Lee M; Gilman-Sachs A; Kwak-Kim J Am J Reprod Immunol; 2013 Nov; 70(5):398-411. PubMed ID: 23656517 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss. Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. Kim JH; Kim SH; Yang N; Ko Y; Lee SR; Chae HD J Korean Med Sci; 2022 Jun; 37(25):e200. PubMed ID: 35762143 [TBL] [Abstract][Full Text] [Related]
14. A novel update on vitamin D in recurrent pregnancy loss (Review). Zhao H; Wei X; Yang X Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760145 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Sapir T; Blank M; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014 [TBL] [Abstract][Full Text] [Related]
18. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss. Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783 [TBL] [Abstract][Full Text] [Related]
19. Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice. Tanaka J; Kitashoji A; Fukunaga Y; Kashihara J; Nakano A; Kamizono A Biol Reprod; 2016 Aug; 95(2):37. PubMed ID: 27335067 [TBL] [Abstract][Full Text] [Related]
20. A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses. Saab W; Seshadri S; Huang C; Alsubki L; Sung N; Kwak-Kim J Am J Reprod Immunol; 2021 Apr; 85(4):e13395. PubMed ID: 33511656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]